Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-19T00:17:16.541Z Has data issue: false hasContentIssue false

Parallel Problems: Applying Institutional Corruption Analysis of Congress to Big Pharma

Published online by Cambridge University Press:  01 January 2021

Extract

In 1995, Dennis Thompson, the founding director of Harvard’s program in Ethics and the Professions, authored a book entitled Ethics in Congress. That subject, in and of itself, seemingly was not new. And it undoubtedly inspired a few irreverent snickers. Consider that a Goggle search of “Ethics in Congress oxymoron” recently produced 5.79 million results in just over a tenth of a second.

But it was the subtitle of the book — From Individual to Institutional Corruption — that revealed how Thompson’s tome signaled an abrupt departure from the standard paradigms for measuring political corruption.

Type
Symposium
Copyright
Copyright © American Society of Law, Medicine and Ethics 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Thompson, D. F., Ethics in Congress: From Individual to Institutional Corruption (Washington, D.C.: The Brookings Institution, 1995): at vii.Google Scholar
Lessig, L., Republic, Lost: How Money Corrupts Congress – and a Plan to Stop It (New York: Twelve, 2011): at xi.Google Scholar
PhRMA, “About,” available at <www.phrma.org/about> (last visited July 18, 2013).+(last+visited+July+18,+2013).>Google Scholar
PhRMA, 2013 Profile, at Appendix 67, available at <http://phrma.org/sites/default/files/pdf/PhRMA%20Profile%202013.pdf> (last visited July 18, 2013).+(last+visited+July+18,+2013).>Google Scholar
Gallup, “Business and Industry Sector Ratings,” available at <http://www.gallup.com/poll/12748/business-industry-sector-ratings.aspx#2> (last visited July 18, 2013).+(last+visited+July+18,+2013).>Google Scholar
Lessig, L., “Institutional Corruptions,” Safra, Edmond J. Working Papers, No. 1, available at <http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2233582> (last visited July 18, 2013).CrossRef+(last+visited+July+18,+2013).>Google Scholar
See Thompson, , supra note 1, at 27.Google Scholar
See Lessig, , supra note 2, at 230.Google Scholar
Id., at 231.Google Scholar
Thompson, D. F., Restoring Responsibility: Ethics in Government, Business and Healthcare (Cambridge, UK: Cambridge University Press, 2005): at 290.Google Scholar
Open Secrets, “2012 Overview,” available at <http://www.opensecrets.org/overview/index.php> (last visited July 18, 2013).+(last+visited+July+18,+2013).>Google Scholar
Lessig, L., “Big Campaign Spending: Government by the 1%,” available at <http://www.theatlantic.com/politics/archive/2012/07/big-campaign-spending-government-by-the-1/259599/> (last visited July 18, 2013).+(last+visited+July+18,+2013).>Google Scholar
See PhRMA, supra note 4, at Appendix 63.Google Scholar
Light, D. W. Lexchin, J., “Pharmaceutical Research and Development: What Do We Get for All That Money?” BMJ 345 (2012): E4348.CrossRefGoogle Scholar
See Thompson, , supra note 12, at 291.Google Scholar
See Lessig, , supra note 2, at 184.Google Scholar
Open Secrets, “Top Industries: 2012,” available at <http://www.opensecrets.org/lobby/top.php?indexType=i&showYear=2012> (last visited July 18, 2013).+(last+visited+July+18,+2013).>Google Scholar
Open Secrets, “Ranked Sectors,” available at <http://www.opensecrets.org/lobby/top.php?indexType=c&showYear=2009> (last visited July 18, 2013).+(last+visited+July+18,+2013).>Google Scholar
Open Secrets, “Top Industries: 2009,” available at <http://www.opensecrets.org/lobby/top.php?indexType=i&showYear=2009> (last visited July 18, 2013).+(last+visited+July+18,+2013).>Google Scholar
Thompson, D. F., “Two Concepts of Corruption: Making Campaigns Safe for Democracy,” George Washington Law Review 73 (2005): 10361069.Google Scholar
See Thompson, , supra note 1, at 110.Google Scholar